Correspondence: Associate Professor Saxon Smith, Department of Dermatology, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia. Email: [email protected]Search for more papers by this author

Kieran B. Garbutcheon-Singh,

Kieran B. Garbutcheon-Singh

orcid.org/0000-0002-4249-7989

Royal North Shore Hospital, Sydney, NSW, Australia

Search for more papers by this author

David J. Curchin,

David J. Curchin

orcid.org/0000-0002-5256-5252

Northern Clinical School, University of Sydney, Sydney, NSW, Australia

Search for more papers by this author

Christopher J. McCormack,

Christopher J. McCormack

Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Search for more papers by this author

Saxon D. Smith,

Corresponding Author

Saxon D. Smith

[email protected]

orcid.org/0000-0003-0995-4372

Royal North Shore Hospital, Sydney, NSW, Australia

Northern Clinical School, University of Sydney, Sydney, NSW, Australia

First published: 19 August 2019

https://doi.org/10.1111/ajd.13131

Citations: 15

Kieran B. Garbutcheon-Singh, PhD, MBBS. David J. Curchin, BBus (Hons), MSt. Christopher J. McCormack, BBus (Hons), MSt. Saxon D. Smith, MBChB, MHL, PhD, FACD.

Share a link

Email
Wechat
Bluesky

Abstract

Background/Objectives

Merkel cell carcinoma (MCC) is a highly invasive cutaneous malignancy. The objective of this study was to investigate the incidence and trends of MCC in Victoria, Australia, between 1986 and 2016.

Methods

Population-based, descriptive analysis of Victorian Cancer Registry (VCR) data. The de-identified records of patients with MCC were obtained from Victoria residents diagnosed between 1986 and 2016. Trends in age-standardised incidences were examined using joinpoint analysis.

Results

A total of 1095 cases were found. Incidence of MCC was 3.9 per 100 000 for men and 1.5 per 100 000 for women. The incidence of MCC in men 66–85 is increasing at an annual rate of 4.2% (2.8–5.8%, 95% CI). However, since 2002 the incidence in women in the same age group has been decreasing. Whilst there is an overall stabilisation in the incidence of MCC, incidence of MCC for males is increasing. For MCC in males 85 years old and over, the incidence of MCC was 26.8 per 100 000 between 2012 and 2016. Relative 5-year survival for patients diagnosed between 2008 and 2012 is 50%.

Conclusion

Merkel cell carcinoma remains an aggressive cancer, especially among older men. Differences in trends seen in local data can help target preventative and early intervention management strategies in specific groups.

References

1Youlden DR, Soyer HP, Youl PH et al. Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010. JAMA Dermatol. 2014; 150: 864–72.
10.1001/jamadermatol.2014.124
PubMed Web of Science® Google Scholar
2Schadendorf D, Lebbé C, zur Hausen A et al. Merkel cell carcinoma: epidemiology, prognosis, therapy and unmet medical needs. Eur. J. Cancer 2017; 71: 53–69.
10.1016/j.ejca.2016.10.022
PubMed Web of Science® Google Scholar
3Amaral T, Leiter U, Garbe C. Merkel cell carcinoma: epidemiology, pathogenesis, diagnosis and therapy. Rev. Endocr. Metab. Disord. 2017; 18: 517–32.
10.1007/s11154-017-9433-0
PubMed Web of Science® Google Scholar
4Heath M, Jaimes N, Lemos B et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J. Am. Acad. Dermatol. 2008; 58: 375–81.
10.1016/j.jaad.2007.11.020
PubMed Web of Science® Google Scholar
5Fitzgerald TL, Dennis S, Kachare SD et al. Dramatic increase in the incidence and mortality from Merkel cell carcinoma in the United States. Am. Surg. 2015; 81: 802–6.
10.1177/000313481508100819
PubMed Web of Science® Google Scholar
6Nghiem P, Carlson RJ. Merkel cell carcinoma. Tumors and Cancers: CRC Press; 2017. p. 31–8.
Google Scholar
7 Australian Bureau of Statistics. 3101.0. Australian demographic statistics, June 2016 (table 52): Australian Bureau of Statistics; 2016 [October 24, 2018]. Available from: http://www.abs.gov.au/AUSSTATS/[email protected]/DetailsPage/3101.0Jun%202016?OpenDocument.
Google Scholar
8Kim H, Fay M, Feuer E et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 2000; 19: 335–51. (correction: 2001;20:655).
10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
CAS PubMed Web of Science® Google Scholar
9 Australian Bureau of Statistics. 3302.0.55.001 - Life Tables, States, Territories and Australia, 2010–2012: Australian Bureau of Statistics; 2013 [November 21, 2018]. Available from: http://www.abs.gov.au/AUSSTATS/[email protected]/Lookup/3302.0.55.001Technical+Note22010-2012.
Google Scholar
10Kaae J, Hansen AV, Biggar RJ et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J. Natl Cancer Inst. 2010; 102: 793–801.
10.1093/jnci/djq120
PubMed Web of Science® Google Scholar
11Zaar O, Gillstedt M, Lindelöf B et al. Merkel cell carcinoma incidence is increasing in Sweden. J. Eur. Acad. Dermatol. Venereol. 2016; 30: 1708–13.
10.1111/jdv.13698
CAS PubMed Web of Science® Google Scholar
12Paulson KG, Park SY, Vandeven NA et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J. Am. Acad. Dermatol. 2018; 78: 457–63.
10.1016/j.jaad.2017.10.028
PubMed Web of Science® Google Scholar
13Girschik J, Thorn K, Beer TW et al. Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival. Br. J. Dermatol. 2011; 165: 1051–7.
10.1111/j.1365-2133.2011.10493.x
CAS PubMed Web of Science® Google Scholar
14Lee A, Garbutcheon-Singh KB, Dixit S et al. The influence of age and gender in knowledge, behaviors and attitudes towards sun protection: a cross-sectional survey of Australian outpatient clinic attendees. Am. J. Clin. Dermatol. 2015; 16: 47–54.
10.1007/s40257-014-0106-4
PubMed Web of Science® Google Scholar
15Kieny A, Cribier B, Meyer N et al. Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France. Int. J. Cancer 2019; 144: 741–5.
10.1002/ijc.31860
CAS PubMed Web of Science® Google Scholar
16Curchin DJ, Harris VR, McCormack CJ et al. Changing trends in the incidence of invasive melanoma in Victoria, 1985–2015. Med. J. Aust. 2018; 208: 265–9.
10.5694/mja17.00725
PubMed Web of Science® Google Scholar
17Stang A, Becker JC, Nghiem P et al. The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment. Eur. J. Cancer 2018; 94: 47–60.
10.1016/j.ejca.2018.02.003
PubMed Web of Science® Google Scholar
18Liu-Smith F, Farhat AM, Arce A et al. Gender differences in the association between the incidence of cutaneous melanoma and geographic UV exposure. J. Am. Acad. Dermatol. 2017; 76: 499–505.
10.1016/j.jaad.2016.08.027
PubMed Web of Science® Google Scholar
19Gies P, Roy C, Javorniczky J et al. Global Solar UV Index: Australian measurements, forecasts and comparison with the UK¶. Photochem. Photobiol. 2004; 79: 32–9.
10.1111/j.1751-1097.2004.tb09854.x
CAS PubMed Web of Science® Google Scholar
20DeCaprio JA. Merkel cell polyomavirus and Merkel cell carcinoma. Phil. Trans. R. Soc. B. 2017; 372: 20160276.
10.1098/rstb.2016.0276
PubMed Web of Science® Google Scholar
21Dabner M, McClure RJ, Harvey NT et al. Merkel cell Polyomavirus and p63 status in Merkel cell carcinoma by immunohistochemistry: merkel cell Polyomavirus positivity is inversely correlated with sun damage, but neither is correlated with outcome. Pathology 2014; 46: 205–10.
10.1097/PAT.0000000000000069
CAS PubMed Web of Science® Google Scholar
22van der Meijden E, Bialasiewicz S, Rockett RJ et al. Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin. PLoS ONE 2013; 8: e81078.
10.1371/journal.pone.0081078
PubMed Web of Science® Google Scholar
23Reichgelt BA, Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993–2007. Eur. J. Cancer 2011; 47: 579–85.
10.1016/j.ejca.2010.11.002
CAS PubMed Web of Science® Google Scholar
24Kukko H, Böhling T, Koljonen V et al. Merkel cell carcinoma–a population-based epidemiological study in Finland with a clinical series of 181 cases. Eur. J. Cancer 2012; 48: 737–42.
10.1016/j.ejca.2011.06.001
PubMed Web of Science® Google Scholar
25Lemos BD, Storer BE, Iyer JG et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J. Am. Acad. Dermatol. 2010; 63: 751–61.
10.1016/j.jaad.2010.02.056
PubMed Web of Science® Google Scholar
26Cancer Queensland. Registry CCQ, Queensland Health. Cancer in Queensland, 1982–2010. Brisbane, Queensland, Australia: CCQ, 2013.
Google Scholar
27Luke JJ, Flaherty KT, Ribas A et al. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat. Rev. Clin. Oncol. 2017; 14: 463.
10.1038/nrclinonc.2017.43
CAS PubMed Web of Science® Google Scholar
28Nghiem PT, Bhatia S, Lipson EJ et al. PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma. N. Engl. J. Med. 2016; 374: 2542–52.
10.1056/NEJMoa1603702
CAS PubMed Web of Science® Google Scholar
29Kaufman HL, Russell JS, Hamid O et al. Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥ 1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial. J. Immunother. Cancer 2018; 6: 7.
10.1186/s40425-017-0310-x
PubMed Web of Science® Google Scholar
30Nghiem P, Bhatia S, Lipson EJ et al. Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy. J. Clin. Oncol. 2019; 37: 693–702.
10.1200/JCO.18.01896
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume61, Issue1

February 2020

Pages e34-e38

Trends in the incidence of Merkel cell carcinoma in Victoria, Australia, between 1986 and 2016

Abstract

Background/Objectives

Methods

Results

Conclusion

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Trends in the incidence of Merkel cell carcinoma in Victoria, Australia, between 1986 and 2016

Abstract

Background/Objectives

Methods

Results

Conclusion

References

Citing Literature

References

Related

Information